Dundarov S, Andonov P
Department of Virology, National Center of Infectious and Parasitic Diseases (NCIPD), Sofia, Bulgaria.
Acta Virol. 1994 Aug;38(4):205-8.
This study reports on our experience with whole herpes simplex vaccines in Bulgaria for a period of 17 years. More than 1,500 immunized patients with herpes ophtalmicus showed a reduction of the recovery period, reduced number of the recurrences and reduced risk of visual damage. More than 14,000 patients suffering from other forms of herpes diseases for a longer period showed reduced recovery period and recurrence frequency in over 95% of the cases. Whole vaccines were well tolerable with no side effects. This report emphasizes the usefulness of whole herpes vaccines.
本研究报告了我们在保加利亚使用全疱疹疫苗17年的经验。1500多名接种了疫苗的单纯疱疹性角膜炎患者恢复期缩短,复发次数减少,视力损害风险降低。超过14000名患有其他形式疱疹疾病更长时间的患者,在超过95%的病例中恢复期缩短且复发频率降低。全疫苗耐受性良好,无副作用。本报告强调了全疱疹疫苗的有效性。